Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
  • 2024-01-30T07:11:55

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg GLIMITERIS TRIO 0.2 Voglibose, Glimepiride, and Metformin Hydrochloride are oral medications used in combination to manage blood sugar levels in people with type 2 diabetes. Each drug works differently, providing a comprehensive approach to blood sugar control: Voglibose: Class: Voglibose is an alpha-glucosidase inhibitor. Mechanism of Action: It works by slowing down the breakdown of complex carbohydrates into glucose, thus reducing the rise in blood sugar levels after meals. Usage: It's particularly effective in controlling postprandial (after-meal) blood glucose levels. Glimepiride: Class: Glimepiride is a sulfonylurea. Mechanism of Action: It increases insulin production in the pancreas, which helps lower blood sugar levels. Usage: It's used to improve glycemic control in adults with type 2 diabetes and is generally taken once a day. Metformin Hydrochloride: Class: Metformin is a biguanide. Mechanism of Action: It works by decreasing glucose production in the liver, decreasing glucose absorption in the intestines, and improving insulin sensitivity, which enhances glucose uptake and utilization by the body’s tissues. Usage: It's often the first medication prescribed for type 2 diabetes and is known for its efficacy and safety profile. The combination therapy targets different aspects of diabetes management: Voglibose reduces rapid glucose absorption post meals. Glimepiride stimulates the pancreas to produce more insulin. Metformin decreases hepatic glucose production and improves insulin sensitivity. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/glimiteris-trio-0-2-134376

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg GLIMITERIS TRIO 0.2 Voglibose, Glimepiride, and Metformin Hydrochloride are oral medications used in combination to manage blood sugar levels in people with type 2 diabetes. Each drug works differently, providing a comprehensive approach to blood sugar control: Voglibose: Class: Voglibose is an alpha-glucosidase inhibitor. Mechanism of Action: It works by slowing down the breakdown of complex carbohydrates into glucose, thus reducing the rise in blood sugar levels after meals. Usage: It's particularly effective in controlling postprandial (after-meal) blood glucose levels. Glimepiride: Class: Glimepiride is a sulfonylurea. Mechanism of Action: It increases insulin production in the pancreas, which helps lower blood sugar levels. Usage: It's used to improve glycemic control in adults with type 2 diabetes and is generally taken once a day. Metformin Hydrochloride: Class: Metformin is a biguanide. Mechanism of Action: It works by decreasing glucose production in the liver, decreasing glucose absorption in the intestines, and improving insulin sensitivity, which enhances glucose uptake and utilization by the body’s tissues. Usage: It's often the first medication prescribed for type 2 diabetes and is known for its efficacy and safety profile. The combination therapy targets different aspects of diabetes management: Voglibose reduces rapid glucose absorption post meals. Glimepiride stimulates the pancreas to produce more insulin. Metformin decreases hepatic glucose production and improves insulin sensitivity. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/glimiteris-trio-0-2-134376

  • 2024-01-30T07:11:55

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us